share_log

领航医药生物科技发布年度业绩 股东应占溢利1.03亿港元同比转亏为盈

Innovative Phar announced its annual performance, with a net profit attributable to shareholders of HK$103 million, turning losses into gains year-on-year.

新浪港股 ·  Jun 30 21:36

In 2024, Innovative Phar (00399) released its annual results for the year ending March 31. The group earned HKD 6,593,000, a decrease of 18.35% compared to the previous year. The company's attributable profit was HKD 103 million, a significant turnaround from the previous year's loss of HKD 246 million. Basic earnings per share were 6.77 HK cents.

According to the announcement, the turnaround from loss to profit was mainly due to the income of approximately HKD 330 million from the revised convertible bonds obtained during the current fiscal year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment